Leaderboards/Aortic aneurysm repair treatments

Aortic aneurysm repair treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Tyler W. Benson
Augusta University
2
Mohamed Elmarasi
Hamad Medical Corporation
3
Xiaoliang Wu
Augusta University
4
Jiateng Hu
Shanghai Jiao Tong University
5
Robert F. Riley
Overlake Hospital Medical Center
6
Jacob Rogatinsky
Boston University
7
Yujian Hu
First Affiliated Hospital Zhejiang University
8
Danya Thayaparan
McMaster University Medical Centre
9
Maryam Fairag
Ministry of Health
10
Mostafa Rezaeitaleshmahalleh
Michigan Technological University

Papers

1
Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection
Journal of Cellular Physiology|2024
116 cit.
2
Publication in Journal of the Society for Cardiovascular Angiography & Interventions (2024) [88 citations, W4391406162]
Journal of the Society for Cardiovascular Angiography & Interventions|2024
88 cit.
3
Robotic Revolution in Surgery: Diverse Applications Across Specialties and Future Prospects Review Article
Cureus|2024
60 cit.
4
Publication in Nature Immunology (2025) [29 citations, W4409682527]
Nature Immunology|2025
29 cit.
5
Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic target
Blood|2024
24 cit.
6
CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up
International Immunopharmacology|2024
14 cit.
7
Publication in Annals of Biomedical Engineering (2024) [8 citations, W4400725340]
Annals of Biomedical Engineering|2024
8 cit.
8
Publication in Annals of Biomedical Engineering (2025) [7 citations, W4407125980]
Annals of Biomedical Engineering|2025
7 cit.
9
A Beating‐Heart Procedure with Soft Robotic Guidance
Advanced Robotics Research|2025
6 cit.
10
Publication in Scientific Reports (2024) [3 citations, W4405016691]
Scientific Reports|2024
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Moritz C. Wyler von Ballmoos
Texas Health Harris Methodist Hospital Fort Worth
2
Lintao Zhong
Chengdu University of Traditional Chinese Medicine
3
Tomas Jonasson
Mission Hospital
4
Zhihui Dong
Hubei University of Medicine
5
Randall R. DeMartino
University of California, Los Angeles
6
Bhama Ramkhelawon
NYU Langone Health
7
Juliette Raffort
Centre National de la Recherche Scientifique
8
J Poniewierski
Antwerp University Hospital
9
H. Pasmans
Amsterdam UMC Location VUmc
10
Emre Yılmaz
Giresun University

Papers

1
The Society of Thoracic Surgeons 2023 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation
The Annals of Thoracic Surgery|2024
87 cit.
2
Characterization of the microenvironment of diabetic foot ulcers and potential drug identification based on scRNA-seq
Frontiers in Endocrinology|2023
35 cit.
3
Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy
Acta Pharmaceutica Sinica B|2022
27 cit.
4
Effects of Sodium-Glucose Co-Transporter-2 Inhibition on Pulmonary Arterial Stiffness and Right Ventricular Function in Heart Failure with Reduced Ejection Fraction
Medicina|2022
24 cit.
5
Incidence, reintervention, and survival associated with type II endoleak at hospital discharge after elective endovascular aneurysm repair in the Vascular Quality Initiative
Journal of Vascular Surgery|2023
16 cit.
6
Implications and late outcomes of type II endoleaks after endovascular aneurysm repair
Journal of Vascular Surgery|2024
16 cit.
7
Safety and Effectiveness of Excimer Laser Ablation Combined With Drug-Coated Balloon for Atherosclerotic Obliterans in the Lower Extremity
Journal of Endovascular Therapy|2022
15 cit.
8
Long‐Term Outcomes of Chronic Type B Aortic Dissection Treated by Thoracic Endovascular Aortic Repair
Journal of the American Heart Association|2022
15 cit.
9
Prediction of 2-Year Major Adverse Limb Event-Free Survival After Percutaneous Transluminal Angioplasty and Stenting for Lower Limb Atherosclerosis Obliterans: A Machine Learning-Based Study
Frontiers in Cardiovascular Medicine|2022
14 cit.
10
Risk factors for at-risk foot and peripheral artery disease among the population with diabetes: A multicommunity-based cross-sectional study
Diabetes Research and Clinical Practice|2023
14 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
David Williams
St George's, University of London
2
Janet T. Powell
University of Cambridge
3
Jan D. Blankensteijn
Radboud University Nijmegen
4
Cathérine Boileau
Hôpital Necker-Enfants Malades
5
Victor Aboyans
The Princess Grace Hospital
6
Robert W. Thompson
Harvard University
7
Hence J.M. Verhagen
Erasmus MC
8
David A. Vorp
University of Pittsburgh
9
Marc L. Schermerhorn
Beth Israel Deaconess Medical Center
10
John A. Elefteriades
Yale University

Papers

1
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Nature Genetics|2003
3k cit.
2
Editor's Choice – European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms
European Journal of Vascular and Endovascular Surgery|2018
2.3k cit.
3
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
Circulation|2010
2.3k cit.
4
A Randomized Trial Comparing Conventional and Endovascular Repair of Abdominal Aortic Aneurysms
New England Journal of Medicine|2004
2k cit.
5
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
Journal of the American College of Cardiology|2010
1.7k cit.
6
Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size
The Annals of Thoracic Surgery|2002
1k cit.
7
Long-Term Outcome of Open or Endovascular Repair of Abdominal Aortic Aneurysm
New England Journal of Medicine|2010
1k cit.
8
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary
Circulation|2010
983 cit.
9
Two-Year Outcomes after Conventional or Endovascular Repair of Abdominal Aortic Aneurysms
New England Journal of Medicine|2005
960 cit.
10
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms
Journal of Clinical Investigation|2000
827 cit.

Reagents for Aortic aneurysm repair treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 68

Calnexin (C5C9) Rabbit Monoclonal Antibody (BSA and Azide Free)

#53191$865
View Evidence →
Bio-RadEvidence 67

RAT ANTI MOUSE CD68

#MCA1957
View Evidence →
Agilent/Dako

Smooth Muscle Actin

#M0635
View Evidence →

🌟 All-Time

Most validated

AbcamEvidence 60

Anti-TAGLN/Transgelin antibody

Cited in 6 papers
#ab14106
View Evidence →
Cell Signaling Technology

CAND1 (D1F2) Rabbit Monoclonal Antibody

Cited in 5 papers
#8759$161,351
View Evidence →
BD Biosciences

Ms CD107b IHC Pure M3/84 1mL

Cited in 5 papers
#550292
View Evidence →